Evidence map›Paper›PMID 38091476›Full record

ArticleJMIR public health and surveillance2024

Impact of the COVID-19 Pandemic on Health Care Utilization in the Vaccine Safety Datalink: Retrospective Cohort Study.

Lei Qian, Lina S Sy, Vennis Hong, Sungching C Glenn, Denison S Ryan, Jennifer C Nelson, Simon J Hambidge, Bradley Crane, Ousseny Zerbo, Malini B DeSilva and 5 more

Open access · goldAbstract read
In one paragraph

Article in JMIR public health and surveillance, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 1 country.

Lei QianResearch and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.ORCID 0000-0001-8001-3992
Lina S SyResearch and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.ORCID 0000-0003-2762-9266
Vennis HongResearch and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.ORCID 0000-0002-6060-8419
Sungching C GlennResearch and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.ORCID 0000-0002-0041-0996
Denison S RyanResearch and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.ORCID 0000-0001-8440-3859
Jennifer C NelsonKaiser Permanente Washington Health Research Institute, Seattle, WA, United States.ORCID 0000-0002-2782-2050
Simon J HambidgeDenver Health Ambulatory Care Services, Denver, CO, United States.ORCID 0000-0002-7535-0668
Bradley CraneCenter for Health Research, Kaiser Permanente Northwest, Portland, OR, United States.ORCID 0009-0006-5525-0324
Ousseny ZerboKaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland, CA, United States.ORCID 0000-0002-8380-6215
Malini B DeSilvaHealthPartners Institute, Bloomington, MN, United States.ORCID 0000-0003-3705-1672
Jason M GlanzInstitute for Health Research, Kaiser Permanente Colorado, Aurora, CO, United States.ORCID 0000-0002-1950-7034
James G DonahueMarshfield Clinic Research Institute, Marshfield, WI, United States.ORCID 0000-0002-5594-7715
Elizabeth LilesCenter for Health Research, Kaiser Permanente Northwest, Portland, OR, United States.ORCID 0000-0002-9669-9252
Jonathan DuffyCenters for Disease Control and Prevention, Atlanta, GA, United States.ORCID 0000-0002-8060-0940
Stanley XuResearch and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.ORCID 0000-0002-4750-7672
Kaiser Permanente · USKaiser Permanente Center for Health Research · USCenters for Disease Control and Prevention · USDenver Health Medical Center · USHealthPartners · USKaiser Permanente Washington Health Research Institute · USMarshfield Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUnderstanding the long-term impact of the COVID-19 pandemic on health care utilization is important to health care organizations and policy makers for strategic planning, as well as to researchers when designing studies that use observational electronic health record data during the pandemic period.

objectiveThis study aimed to evaluate the changes in health care utilization across all care settings among a large, diverse, and insured population in the United States during the COVID-19 pandemic.

methodsWe conducted a retrospective cohort study within 8 health care organizations participating in the Vaccine Safety Datalink Project using electronic health record data from members of all ages from January 1, 2017, to December 31, 2021. The visit rates per person-year were calculated monthly during the study period for 4 health care settings combined as well as by inpatient, emergency department (ED), outpatient, and telehealth settings, both among all members and members without COVID-19. Difference-in-difference analysis and interrupted time series analysis were performed to assess the changes in visit rates from the prepandemic period (January 2017 to February 2020) to the early pandemic period (April-December 2020) and the later pandemic period (July-December 2021), respectively. An exploratory analysis was also conducted to assess trends through June 2023 at one of the largest sites, Kaiser Permanente Southern California.

resultsThe study included more than 11 million members from 2017 to 2021. Compared with the prepandemic period, we found reductions in visit rates during the early pandemic period for all in-person care settings. During the later pandemic period, overall use reached 8.36 visits per person-year, exceeding the prepandemic level of 7.49 visits per person-year in 2019 (adjusted percent change 5.1%, 95% CI 0.6%-9.9%); inpatient and ED visits returned to prepandemic levels among all members, although they remained low at 0.095 and 0.241 visits per person-year, indicating a 7.5% and 8% decrease compared to pre-pandemic levels among members without COVID-19, respectively. Telehealth visits, which were approximately 42% of the volume of outpatient visits during the later pandemic period, were increased by 97.5% (95% CI 86.0%-109.7%) from 0.865 visits per person-year in 2019 to 2.35 visits per person-year in the later pandemic period. The trends in Kaiser Permanente Southern California were similar to those of the entire study population. Visit rates from January 2022 to June 2023 were stable and appeared to be a continuation of the use levels observed at the end of 2021.

conclusionsTelehealth services became a mainstay of the health care system during the late COVID-19 pandemic period. Inpatient and ED visits returned to prepandemic levels, although they remained low among members without evidence of COVID-19. Our findings provide valuable information for strategic resource allocation for postpandemic patient care and for designing observational studies involving the pandemic period.

Indexed as

COVID-19TelemedicineVaccinesHumansPandemicsPatient Acceptance of Health CareRetrospective StudiesVaccinesCOVID-19 pandemicdifference-in-differenceelectronic health recordemergency departmenthealth care utilizationinpatientinterrupted time series analysisoutpatientresource allocationtelehealthvaccine safety

Identifiers

PMID38091476
PMCPMC10807656
OpenAlexW4389631333

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.